
Fast-Tracking Hope: Early-Stage Planning for Rare Disease Drug Development
The journey of developing effective treatments for rare diseases, particularly in a pediatric population, has its own unique challenges, including (but not limited to), a small population size, disease heterogeneity, and the absence of established endpoints to support regulatory decisionmaking. While regulatory authorities have special